Distinct actions of prednisolone and dexamethasone towards osteocalcin and eosinophilic cationic protein in assumed clinically equivalent doses: A study in healthy men

European Journal of Clinical Pharmacology

Volumn 58, Issue 11, 2003, Pages 733-737

  Dubois, E F L ^a   Derks, M G M ^b   Zwinderman, A H ^b   Dekhuijzen, P N R ^c   Boxtel, C J V ^b   Schweitzer, D H ^a  

^a REINIER DE GRAAF HOSPITAL   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cortisol; Dexamethasone; Eosinophilic cationic protein

Indexed keywords

ANTIINFLAMMATORY AGENT; DEXAMETHASONE; EOSINOPHIL CATIONIC PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROCORTISONE; OSTEOCALCIN; PREDNISOLONE; SODIUM CHLORIDE;

ADULT; ANTIINFLAMMATORY ACTIVITY; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZATION;

EID: 0037354446     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-002-0549-z     Document Type: Article

References (25)

1. Marble A, Selenkow HA, Rose LI, Dluhy RG, Williams GH (1980) Endocrine diseases. In: Avery GS (ed) Drug treatment, 2nd edn. Churchill Livingstone, Edinburgh, p 530
2. Babadjanova G, Allolio B, Vollmer M, Reincke M, Schulte HM (1996) Comparison of the pharmacodynamic effects of deflazacort and prednisolone in healthy subjects. Eur J Clin Pharmacol 51:53-57
3. Montecucco C, Baldi F, Fortina A, Tomassini G, Caporali R, Cherie-Ligniere EL, Fratino P (1988) Serum osteocalcin (bone Gla-protein) following corticosteroid therapy in postmenopausal women with rheumatoid arthritis. Comparison of the effect of prednisone and deflazacort. Clin Rheumatol 7:366-371
4. LoCascio V, Ballanti P, Milani S, Bertoldo F, LoCascio C, Zanolin EM, Bonucci E (1998) A histomorphometric long-term longitudinal study of trabecular bone loss in glucocorticoid-treated patients: prednisone versus deflazacort. Calcif Tissue Int 62:199-204
5. Wever AM, Wever Hess J, Hermans J (1997) The use of serum eosinophil cationic protein (ECP) in the management of steroid therapy in chronic asthma. Clin Exp Allergy 27:519-529
6. Karawajczyk M, Höglund M, Ericsson J, Venge P (1997) Administration of G-CSF to healthy subjects: the effects on eosinophil counts and mobilization of eosinophil granule proteins. Br J Haematol 96:259-265
7. Ekenstam E, Stålenheim G, Hällgren R (1988) The acute effect of high dose corticosteroid treatment on serum osteocalcin. Metabolism 37:141-144
8. Godschalk MF, Downs RW (1988) Effect of short-term glucocorticoids on serum osteocalcin in healthy young men. J Bone Miner Res 3:113-115
9. Khosla S, Kleerekoper M (1999) Biochemical markers of bone turnover. In: Favus MJ, Goldring SR, Christakos S (eds) Primer on the bone diseases and disorders of mineral metabolism, 4th edn. Lippincott Williams and Wilkins, Philadelphia, pp 128-134
10. Epstein S (1988) Serum and urinary markers of bone remodeling: assessment of bone turnover. Endocrine Rev 9:437-449
11. Szulc P, Seeman E, Delmas PD (2000) Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int 11:281-294
12. Wald J, Jusko W(1992) Corticosteroid pharmacodynamic modelling: osteocalcin suppression by prednisolone. Pharm Res 9:1096-1098
13. Nielsen H, Charles P, Moskilde L (1988) The effect of single oral doses of prednisolone in circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab 67:1025-1030
14. Nielsen HK, Laurberg P, Brixen K, Mosekilde L (1991) Relations between diurnal variations in serum osteocalcin, cortisol, parathyroid hormone, and ionized calcium in normal individuals. Acta Endocrinol 124:391-398
15. Nielsen HK, Brixen K, Kassem M, Charles P, Moskilde L (1992) Inhibition of the morning cortisol peak abolishes the expected morning decrease in serum osteocalcin in normal males: evidence of a controlling effect of serum cortisol on the circadian rhythm in serum osteocalcin. J Clin Endocrinol Metab 74:1410-1414
16. Heshmati HM, Riggs BL, Burritt MF, Mc Allister CA, Wollan PC, Khosla S (1998) Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopauzal women. J Clin Endocrinol Metab 83:751-756
17. Denburg JA (1997) Effects of corticosteroids on basophils and mast cells. In: Schleimer RP, Busse WW, O'Byrne PM (eds) Lung biology in health and disease. Marcel Dekker Inc., New York, pp 259-277
18. Barnes PJ, Fan Chung K, Page CP (1998) Inflammatory mediators of asthma: an update. Pharmacol Rev 50:515-596
19. Chung KF, Barnes PJ (1999) Cytokines in asthma. Thorax 54:825-857
20. Pronk-Admiraal CJ, Bartels PC, Mulder K (1999) Eosinophil cationic protein in serum from nonatopic and asymptomatic atopic individuals after standardized blood clotting at 37 degrees C. Ann Clin Biochem 36:353-358
21. Peterson CG, Enander I, Nystrand J, Anderson AS, Nilsson L, Venge P (1991) Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clin Exp Allergy 21:561-567
22. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM (1994) Commercial essays for serum osteocalcin give clinically discordant results. Clin Chem 40:358-363
23. Braat MC, Oosterhuis B, Koopmans RP, Meewis JM, Van Boxtel CJ (1992) Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethason and hydrocortisone in humans, after inhalation and intravenous administration of dexamethason. J Pharmacol Exp Ther 262:509-515
24. Maillefert JF, Aho S, Huguenin MC, Chatard C, Peere T, Marquinon MF, Lucas B, Tavernier C (1995) Systemic effects of epidural dexamethasone injections. Rev Rheum 62:429-432
25. Toutain PL, Brandon RA, de Pomyers H, Alvinerie M, Baggot JD (1984) Dexamethasone and prednisolone in the horse: pharmacokinetics and action on the adrenal gland. Am J Vet Res 45:1750-1756